3 results
Approved WMOCompleted
Primary Objective:To evaluate the efficacy and safety of solifenacin succinate o.d. in children and adolescents with OABSecondary Objective:To perform population pharmacokinetics after multiple-dose administration.
Approved WMOCompleted
To evaluate the safety and efficacy of solifenacin succinate suspension once daily in children and adolescents with OAB.
Approved WMORecruiting
Assessment of safety and clinical performance of the DREAMS 3G in de novo coronary artery lesion in order to achieve and to obtain CE-approval